Europe Wakes Up: The Coming Alliance Boom
Executive Summary
Mid-size European drug companies have always been reluctant suitors when it comes to doing deals with US biotech companies. But judging by attendance at this year's Euro-Biotech Forum, they've gotten religion. Late-stage deal-making, still favored, is down, while more companies are willing to do research-stage deals.